In Vitro Diagnostic Chip Research:expanding at a compound annual growth rate (CAGR) of 8.3%

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "In Vitro Diagnostic Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for In Vitro Diagnostic Chip was estimated to be worth US$ 2895 million in 2024 and is forecast to a readjusted size of US$ 5059 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4719015/in-vitro-diagnostic-chip



Global In Vitro Diagnostic Chip Market to Grow at 8.3% CAGR through 2031

The global market for In Vitro Diagnostic Chip technology is undergoing a period of rapid evolution. Valued at US$ 2.9 billion in 2024, the market is projected to reach US$ 5.1 billion by 2031, expanding at a compound annual growth rate (CAGR) of 8.3%. According to the newly released "Global In Vitro Diagnostic Chip Market Research Report 2025" by QYResearch, this growth is driven by technological innovation, increasing demand for point-of-care diagnostics, and a rise in chronic and infectious diseases.
Market Dynamics and Emerging Trends
1. AI and Microfluidics Integration
Enhanced Diagnostic Speed and Precision: The integration of AI algorithms with microfluidic platforms accelerates data analysis, leading to quicker and more accurate diagnostics.
Lab-on-a-Chip Advancements: AI-driven microfluidic devices are central to the LOC industry, enabling real-time monitoring and decision-making in clinical settings.
Personalized Medicine: AI facilitates the interpretation of complex biological data from LOC devices, supporting tailored treatment plans for patients.
2. Multiplexed Point-of-Care Testing
Simultaneous Biomarker Detection: Multiplexed LOC systems can detect multiple biomarkers from a single sample, improving diagnostic efficiency.
Resource-Constrained Environments: These systems are particularly beneficial in settings with limited laboratory infrastructure, providing rapid and comprehensive testing.
Emerging Applications: The technology is expanding into areas such as infectious disease detection, cancer diagnostics, and environmental monitoring.
3. Impact of 2025 U.S. Tariff Policies
Strategic Uncertainty: New U.S. tariffs have introduced complexities in global supply chains, affecting sourcing and distribution strategies for LOC components.
Regional Production Dynamics: Companies are reevaluating manufacturing locations, with a shift towards regional production to mitigate tariff impacts.
Innovation in Manufacturing: The need for cost-effective production has spurred advancements in LOC manufacturing processes, including automation and alternative materials.
4. Market Growth and Trends
Government Initiatives: Increased funding and support for personalized medicine and decentralized testing are driving market growth.
Technological Innovations: Advances in microfluidics, AI integration, and portable diagnostics are expanding the applications of LOC devices.
Key Applications and Product Segmentation
In Vitro Diagnostic Chips are used extensively in:
Infectious Disease Detection
Cancer Screening and Monitoring
Chronic Disease Management
Genetic Disorder Testing
Other diagnostic applications
The market is segmented by product type into:
Nucleic Acid Detection Chips
Protein Detection Chips
Cell Analysis Chips
Multiplex Analysis Chips
Others
Regional and Competitive Landscape
Regionally, North America, Europe, and Asia-Pacific dominate the global landscape. Asia-Pacific, particularly China and India, is expected to witness the fastest growth due to expanding healthcare access and increased government investment in biotech infrastructure.
The report profiles leading manufacturers, including:
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
bioMérieux
QIAGEN
Thermo Fisher Scientific
Agilent Technologies
Illumina
PerkinElmer
Merck KGaA
Becton, Dickinson and Company
Sysmex Corporation
Biotronik
Randox Laboratories
In Vitro Diagnostic Chip Product Models by Company
Roche Diagnostics
cobas® Liat PCR System - Rapid molecular point-of-care testing platform
cobas® 6800/8800 Systems - High-throughput molecular diagnostic systems
Elecsys® Anti-SARS-CoV-2 - Immunoassay for COVID-19 antibodies
cobas® Infinity - Lab workflow and data management software
Siemens Healthineers
CLINITEK Status®+ Analyzer - Urinalysis system
Atellica® Solution - Immunoassay and clinical chemistry analyzer
ADVIA Centaur® CP System - Immunoassay system
Fast Track Diagnostics (FTD) - Multiplex PCR assays
Abbott Laboratories
i-STAT Alinity System - Handheld blood analyzer for point-of-care
ID NOWTM - Molecular POC testing for influenza, strep, and COVID-19
ARCHITECT i1000SR - Immunoassay analyzer
m2000 RealTime System - High-throughput PCR testing
bioMérieux
BIOFIRE® FilmArray® Panels - Syndromic testing panels for respiratory, GI, and meningitis/encephalitis
VIDAS® - Multiparametric immunoassay platform
SPOTFIRE® - Next-gen POC system for emergency diagnostics
BACT/ALERT® - Blood culture and microbial detection system
QIAGEN
QIAstat-Dx - Syndromic PCR testing system
QIAcuity - Digital PCR platform
NeuMoDx - Automated real-time PCR system
QIAamp Viral RNA Mini Kit - Manual viral RNA extraction kit
Key Downstream Customers
Jena University Hospital
SHK Weimar Hospital
Leeds Teaching Hospitals NHS Trust
Vanderbilt University Medical Center
QIAGEN QIAstat-Dx Global Hospital Network
Hôpital Bichat-Claude Bernard
University Medical Center Utrecht
Cleveland Clinic
National University Hospital Singapore
All India Institute of Medical Sciences
Charité - Universitätsmedizin Berlin
Notable Innovations in 2025
bioMérieux continues its market expansion through the release of its BIOFIRE GI-Mid panel and acquisition of SpinChip, strengthening its point-of-care diagnostics portfolio. Meanwhile, Emulate, Inc. has introduced the Chip-R1 Rigid Chip, designed to minimize drug absorption and optimize biological modeling accuracy in preclinical testing.
Other companies like Roche and QIAGEN are focusing on integrating chip technologies into broader personalized medicine ecosystems, emphasizing real-time data analytics and predictive diagnostics.

With robust growth ahead and a surge in innovation, the In Vitro Diagnostic Chip market is poised to reshape global diagnostics. Investments in AI, miniaturization, and decentralized testing continue to drive this transformation, making it a focal point of healthcare modernization from 2025 onward.
Get free Sample report:

Global In Vitro Diagnostic Chip Market Research Report 2025
https://www.qyresearch.com/reports/4719024/in-vitro-diagnostic-chip

Global In Vitro Diagnostic Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
https://www.qyresearch.com/reports/4719022/in-vitro-diagnostic-chip

Global In Vitro Diagnostic Chip Market Insights, Forecast to 2031
https://www.qyresearch.com/reports/4719017/in-vitro-diagnostic-chip

In Vitro Diagnostic Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
https://www.qyresearch.com/reports/4719015/in-vitro-diagnostic-chip



The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The In Vitro Diagnostic Chip market is segmented as below:
By Company
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
bioMérieux
QIAGEN
Thermo Fisher Scientific
Agilent Technologies
Illumina
PerkinElmer
Merck KGaA
Becton, Dickinson and Company
Sysmex Corporation
Biotronik
Randox Laboratories

Segment by Type
Nucleic Acid Detection Chips
Protein Detection Chips
Cell Analysis Chips
Multiplex Analysis Chips
Others

Segment by Application
Infectious Disease Detection
Cancer Screening and Monitoring
Chronic Disease Management
Genetic Disorder Testing
Others

Each chapter of the report provides detailed information for readers to further understand the In Vitro Diagnostic Chip market:

Chapter 1: Introduces the report scope of the In Vitro Diagnostic Chip report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)
Chapter 2: Detailed analysis of In Vitro Diagnostic Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)
Chapter 3: Provides the analysis of various In Vitro Diagnostic Chip market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)
Chapter 5: Sales, revenue of In Vitro Diagnostic Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)
Chapter 6: Sales, revenue of In Vitro Diagnostic Chip in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth In Vitro Diagnostic Chip competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides In Vitro Diagnostic Chip comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides In Vitro Diagnostic Chip market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global In Vitro Diagnostic Chip Market Research Report 2025
Global In Vitro Diagnostic Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global In Vitro Diagnostic Chip Market Insights, Forecast to 2031
Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Outlook, InDepth Analysis & Forecast to 2031
Global Polymer Microfluidic Chips for in Vitro Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Polymer Microfluidic Chips for in Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Research Report 2025
Global and United States Polymer Microfluidic Chips for in Vitro Diagnostics Market Report & Forecast 2024-2030
Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Insights, Forecast to 2030
Polymer Microfluidic Chips for in Vitro Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Polymer Microfluidic Chips for in Vitro Diagnostics Market Research Report 2024

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

This release was published on openPR.